Korean Drug Companies Eye Overseas Markets
SEOUL, Jan. 24 (Korea Bizwire) — South Korea’s major pharmaceuticals manufacturers have set their sights on overseas markets this year as a string of their biosimilars are waiting to be approved or launched, industry sources said Friday. Celltrion Inc. said sales of its drug Remsima SC for the treatment of autoimmune diseases are set to [...]